首页 > 市场调查报告书 > 医疗设备

生技设备

全球次世代定序(NGS) 市场，按产品类型、技术、工作流程、服务和应用划分 - 预测至 2029 年

市场调查报告书

商品编码

1648505

全球次世代定序(NGS) 市场，按产品类型、技术、工作流程、服务和应用划分 - 预测至 2029 年

Next-Generation Sequencing Market by Product Type (Consumables, Platforms, Bioinformatics), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Services, Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2029

出版日期: 2025年01月28日 | 出版商:

MarketsandMarkets | 英文 714 Pages | 订单完成后即时交付

价格

简介目录图表

全球次世代定序(NGS) 市场规模预计将从 2024 年的 132.8 亿美元增至 2029 年的 223.8 亿美元，预测期内的复合年增长率为 11.0%。

研究范围
调查年份	2022-2029
基准年	2023
预测期	2024-2029
单元	美元
部分	产品、产品类型、平台技术、产品工作流程、产品最终使用者、服务类型、服务工作流程、用途
目标区域	北美、欧洲、亚太地区、拉丁美洲、中东和非洲

NGS 在肿瘤学、感染疾病、生殖医学、总体基因体学和个人化医疗等领域的应用日益广泛，是主要的成长动力。此外，用于资料分析和解释的生物资讯工具的改进使得NGS更易于使用，并有助于推动其广泛应用。

“按产品划分，消耗品部分在 2023 年占据了最大的市场份额。”

耗材部分在NGS市场的产品类型类别中占据主导地位。其中包括试剂、文库製备试剂套件、定序流动池、样品製备试剂套件等，它们在各种应用中被大量消耗。与一次性购买的仪器不同，对优质耗材的持续需求确保了稳定的需求。此外，标靶定序和自订面板的日益普及正在推动对特定研究和临床应用的专用耗材的需求。 NGS 用户数量的不断增长以及定序化学技术的进步推动了对耗材的越来越依赖，以优化工作流程并提高资料品质。

“按服务终端用户划分，学术和研究机构部门在 2023 年占据了最大的市场份额。”

学术和研究机构的份额很大是因为这些机构获得了大量政府和私人研究计划资金，使得它们能够大量投资于NGS产品，包括仪器和消耗品。同时，製药和生技公司在该领域占有第二大份额。

“预计 2024 年至 2029 年期间，亚太地区的 NGS 市场复合年增长率最高。”

由于大规模人口基因组学计划，亚太地区估计将成为市场成长最快的部分，而精准医疗的不断增长的需求正在支撑其增长。此外，罕见疾病和遗传疾病的发生率不断上升是由于日本和中国等国家的人口老化。这支持了定序技术在医疗管理和治疗中的应用，从而推动了市场成长。

本报告对全球次世代定序(NGS) 市场进行了深入分析，包括关键驱动因素和限制因素、竞争格局和未来趋势。

介绍
市场动态
- 驱动程式
- 限制因素
- 机会
- 任务
影响客户业务的趋势/干扰
监管格局
- 监管机构、政府机构和其他组织
- 法规结构
价值链分析
技术分析
- 关键技术
- 互补技术
- 相关技术
定价分析
- 平均销售价格趋势：依主要企业划分
- 平均销售价格：按地区
专利分析
供应链分析
生态系分析
重大会议和活动（2024-2025 年）
波特五力分析
主要相关利益者和采购标准
投资金筹措场景
案例研究分析
贸易分析
- 导入资料
- 汇出资料
人工智慧对次世代定序(NGS) 市场的影响

第六章次世代定序(NGS) 市场依产品分类

介绍
产品
服务

第七章次世代定序(NGS) 产品市场依类型

介绍
耗材
平台
生物资讯学工具

第 8 章次世代定序(NGS) 平台市场（按技术）

介绍
合成定定序
离子半导体定序
SMRT定序
奈米孔定序
其他定序技术

第 9次世代定序。

介绍
定序
预测定序
资料分析

第 10 章次世代定序(NGS) 产品市场（按最终用户划分）

介绍
学术和研究机构
製药和生物技术公司
临床和诊断实验室
其他最终用户

第 11 章次世代定序(NGS) 服务市场（按类型）

介绍
定序服务
预测定序服务
生物资讯学和资料分析服务
NGS平台服务

第 12 章次世代定序(NGS) 服务市场（依工作流程）

介绍
定序
预测定序服务
资料分析服务

第 13 章次世代定序(NGS) 服务市场（依最终用户）

介绍
学术和研究机构
製药和生物技术公司
医院和临床实验室
其他最终用户

第 14 章次世代定序(NGS) 市场（按应用）

介绍
诊断
药物研发
农业和动物研究
其他用途

第 15 章次世代定序(NGS) 市场（按地区）

介绍
北美洲
- 北美宏观经济展望
- 美国
- 加拿大
欧洲
- 欧洲宏观经济展望
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 荷兰
- 欧洲其他地区
亚太地区
- 亚太宏观经济展望
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 其他亚太地区
拉丁美洲
- 拉丁美洲宏观经济展望
- 巴西
- 墨西哥
- 其他拉丁美洲国家
中东
- 中东宏观经济展望
- 海湾合作委员会国家
- 其他中东地区
非洲

第十六章竞争格局

介绍
主要参与企业的策略/优势
收益分析（2019-2023）
市场占有率分析（2023 年）
企业评估矩阵：主要企业（2023 年）
公司评估矩阵：Start-Ups/中小企业（2023 年）
估值及财务指标
品牌/产品比较
竞争场景

第十七章公司简介

主要企业
- ILLUMINA, INC.
- THERMO FISHER SCIENTIFIC INC.
- AGILENT TECHNOLOGIES, INC.
- F. HOFFMANN-LA ROCHE LTD.
- DANAHER CORPORATION
- QIAGEN
- REVVITY
- EUROFINS SCIENTIFIC
- PACBIO
- OXFORD NANOPORE TECHNOLOGIES PLC.
- TAKARA BIO INC.
- BGI GROUP
- BD
- 10X GENOMICS
- PROMEGA CORPORATION
- LGC LIMITED
- WUXI BIOLOGICS
- TECAN TRADING AG
- TWIST BIOSCIENCES
- AZENTA US, INC.
其他公司
- MGI TECH CO. LTD.
- NOVOGENE CO., LTD.
- NEW ENGLAND BIOLABS
- GENSCRIPT
- PSOMAGEN
- ZYMO RESEARCH CORPORATION
- HAMILTON COMPANY
- NEOGENOMICS LABORATORIES
- FULGENT GENETICS
- SD BIOSENSOR, INC.

第十八章附录

简介目录图表

Product Code: BT 2697

The next-generation sequencing market is expected to reach USD 22.38 billion in 2029 from USD 13.28 billion in 2024, at a CAGR of 11.0% during the forecast period.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	Offerings, Product Type, Platform Technology, Product Workflow, Product End User, Service Type, Service Workflow, Application
Regions covered	North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa

The increasing adoption of NGS in areas like oncology, infectious diseases, reproductive health, metagenomics, and personalized medicine is a major growth driver. Moreover, improved bioinformatics tools for data analysis and interpretation are enhancing the usability of NGS, driving its widespread adoption.

"The consumables segment accounted for the largest share by products segment in the NGS market in 2023"

The NGS products market is divided into consumables, platforms, and bioinformatics tools. The consumables holds the largest share of the market in 2023. The consumables is the segment with the largest share in products. The consumables segment dominates the product type category of the NGS market. These include reagents, library preparation kits, sequencing flow cells, and sample preparation kits, which are consumed in large volumes across diverse applications. The ongoing need for high-quality consumables ensures a steady demand, unlike instruments that represent one-time purchases. Additionally, the increasing adoption of targeted sequencing and custom panels drives the demand for specialized consumables tailored for specific research and clinical applications. The growing number of NGS users, coupled with advancements in sequencing chemistries, has further increased the reliance on consumables to optimize workflows and improve data quality.

"The academic & research institutes segment accounted for the largest share by services end-user segment in the NGS market in 2023"

The NGS services market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, hospitals & clinical laboratories, and other end users. The academic & research institutes are the segment with the largest share in the end-user segment in 2023. The large share of academic & research institutes is due to these institutions benefit from substantial government and private funding for research projects, enabling significant investments in NGS products, including instruments and consumables. However, the pharmaceutical & biotechnological companies accounted for the second largest share in the segment.

"The Asia Pacific region is growing at the highest CAGR in the NGS market from 2024 to 2029."

The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the large scale of population genomics projects, and the rising demand for precision medicines is supporting the growth. Further, the rising prevalence of rare and genetic diseases is attributed to the aging population of countries such as Japan, and China. This is supporting the adoption of sequencing technologies in healthcare management and treatment driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

Illumina, Inc. (US)
Thermo Fisher Scientific Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Danaher Corporation (US)
QIAGEN (Netherlands)
Agilent Technologies, Inc. (US)
Revvity (US)
Eurofins Scientific (Luxembourg)
PacBio (US)
Oxford Nanopore Technologies plc. (UK)
Takara Bio Inc. (Japan)
BGI Group (China)
Merck KGaA (Germany)
BD (US)
10X Genomics (US)
New England Biolabs (US)
Promega Corporation (US)
Novogene Co., Ltd. (China)
LGC Limited (UK)
WuXi Biologics (China)
MGI Tech Co. Ltd. (China)
Tecan Trading AG (Switzerland)
Twist Biosciences (US)
Azenta US, Inc. (US)
GenScript (US)
SD Biosensor, Inc. (South Korea)
Fulgent Genetics (US)
Hamilton Company (US)
Zymo Research Corporation (US)
NeoGenomics Laboratories (US)
Psomagen (US)

Research Coverage:

This research report categorizes the NGS market by offerings (products and services), products by type (consumables, platforms, bioinformatics tools), consumables (library preparation kits & reagents, sequencing kits & reagents, and other consumables), platforms (sequencing platforms, library preparation platforms), bioinformatics tools (data analysis software & workbenches, data visualization tools, and other tools), platforms by technology (sequencing by synthesis, ion semiconductor sequencing, single-molecule real time sequencing, nanopore sequencing, and other sequencing technologies), products by workflow (presequencing, sequencing , and data analysis), products by end user (academic and research institutes, pharmaceutical and biotechnology companies, clinical & diagnostics laboratories, and other end users), services by type (sequencing services, presequencing services, bioinformatics and data analysis services, and services for NGS platforms), presequencing services by type (library preparation & target enrichment, sample preparation, and quality control), sequencing services by type (exome & targeted resequencing and custom panels, rna sequencing, de novo sequencing, chip sequencing, whole genome sequencing, methyl sequencing, and other sequencing services), bioinformatics & data analysis services by type (data analysis services, data visualization and interpretation, data storage and management services), services by workflow (presequencing services, sequencing services, and data analysis services), servuces by end user (academics and research institutes, pharmaceutical and biotechnology companies, hospitals and clinical laboratories, other end users), application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), diagnostic applications (cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics, and other diagnostic applications), drug discovery & development application (pharmacogenomics, and other drug discovery & development applications), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the NGS market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the NGS market. Competitive analysis of top players and upcoming startups in the NGS market ecosystem is covered in this report

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NGS market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Advancements in sequencing platforms, Rising clinical applications of sequencing, Growing demand for precision medicine, Declining sequencing cost), restraints (Data analysis complexity, High initial capital investment), opportunities (Integration of AI and ML, adoption of long-read sequencing technologies, emphasis on multiomics integration), and challenges (Standardization issues) influencing the growth of the market.

Product Development/Innovation: Detailed insights on newly launched products/services of the NGS market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the genomics market
Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), Merck KGaA (Germany), BD (US), 10X Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co. Ltd. (China), Tecan Trading AG (Switzerland), Twist Biosciences (US), Azenta US, Inc. (US), GenScript (US), SD Biosensor, Inc. (South Korea), Fulgent Genetics (US), Hamilton Company (US), Zymo Research Corporation (US), NeoGenomics Laboratories (US), and Psomagen (US).

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SEGMENTATION
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 GLOBAL MARKET ESTIMATION
- 2.2.2 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 NGS MARKET OVERVIEW
4.2 ASIA PACIFIC: NGS MARKET, BY COUNTRY AND PRODUCT TYPE
4.3 NGS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 NGS PRODUCTS MARKET SHARE, BY END USER, 2023

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Advancements in sequencing platforms
    - 5.2.1.1.1 Revio
    - 5.2.1.1.2 PromethION 2 Solo
    - 5.2.1.1.3 Ion Torrent Genexus Dx
  - 5.2.1.2 Rising clinical applications of sequencing
  - 5.2.1.3 Growing demand for precision medicine
  - 5.2.1.4 Declining costs of sequencing
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Data analysis complexity
  - 5.2.2.2 High capital investment and expenses
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Integration of AI and ML
  - 5.2.3.2 Adoption of long-read sequencing technologies
  - 5.2.3.3 Emphasis on multiomics integration
- 5.2.4 CHALLENGES
  - 5.2.4.1 Standardization issues
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 REGULATORY LANDSCAPE
- 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.4.2 REGULATORY FRAMEWORK
5.5 VALUE CHAIN ANALYSIS
5.6 TECHNOLOGY ANALYSIS
- 5.6.1 KEY TECHNOLOGIES
  - 5.6.1.1 Sequencing by synthesis
  - 5.6.1.2 Single-molecule real-time sequencing
  - 5.6.1.3 Nanopore sequencing
  - 5.6.1.4 Ion semiconductor sequencing
- 5.6.2 COMPLEMENTARY TECHNOLOGIES
  - 5.6.2.1 Automated sample preparation systems
  - 5.6.2.2 Bioinformatics and data analysis platforms
  - 5.6.2.3 CRISPR-based targeted sequencing
  - 5.6.2.4 Multiplex PCR
- 5.6.3 ADJACENT TECHNOLOGIES
  - 5.6.3.1 Single-cell sequencing technology
  - 5.6.3.2 Multi-omics integration
  - 5.6.3.3 Spatial genomics and transcriptomics
  - 5.6.3.4 Gene editing technologies
5.7 PRICING ANALYSIS
- 5.7.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  - 5.7.1.1 Average selling price trend of instruments, by key player, 2018-2023
  - 5.7.1.2 Average selling price trend of consumables, by key player, 2022-2024
  - 5.7.1.3 Average selling price of services, by key player, 2024
- 5.7.2 AVERAGE SELLING PRICE, BY REGION
5.8 PATENT ANALYSIS
5.9 SUPPLY CHAIN ANALYSIS
5.10 ECOSYSTEM ANALYSIS
5.11 KEY CONFERENCES AND EVENTS, 2024-2025
5.12 PORTER'S FIVE FORCES ANALYSIS
- 5.12.1 INTENSITY OF COMPETITIVE RIVALRY
- 5.12.2 BARGAINING POWER OF SUPPLIERS
- 5.12.3 BARGAINING POWER OF BUYERS
- 5.12.4 THREAT OF SUBSTITUTES
- 5.12.5 THREAT OF NEW ENTRANTS
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.13.2 KEY BUYING CRITERIA, BY END USER
5.14 INVESTMENT AND FUNDING SCENARIO
5.15 CASE STUDY ANALYSIS
- 5.15.1 CASE STUDY 1: IDENTIFYING TANDEM REPEAT LINKED TO ALS USING SMRT SEQUENCING
- 5.15.2 CASE STUDY 2: LONG-READ WHOLE-GENOME SEQUENCING AT CHILDREN'S MERCY KANSAS CITY
- 5.15.3 CASE STUDY 3: SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES
5.16 TRADE ANALYSIS
- 5.16.1 IMPORT DATA
- 5.16.2 EXPORT DATA
5.17 IMPACT OF AI ON NEXT-GENERATION SEQUENCING MARKET

6 NEXT-GENERATION SEQUENCING MARKET, BY OFFERING

6.1 INTRODUCTION
6.2 PRODUCTS
- 6.2.1 WIDE DEMAND FOR CONSUMABLES AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL MARKET
6.3 SERVICES
- 6.3.1 SHIFT TOWARD SERVICE-BASED MODELS TO DRIVE MARKET

7 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY TYPE

7.1 INTRODUCTION
7.2 CONSUMABLES
- 7.2.1 LIBRARY PREPARATION & AND REAGENTS
  - 7.2.1.1 Strong demand and growing applications to ensure market growth
- 7.2.2 SEQUENCING KITS & REAGENTS
  - 7.2.2.1 Technological advancements to support market growth
- 7.2.3 OTHER CONSUMABLES
7.3 PLATFORMS
- 7.3.1 SEQUENCING PLATFORMS
  - 7.3.1.1 Illumina
    - 7.3.1.1.1 NovaSeq
      - 7.3.1.1.1.1 Flexibility and automated data processing to reduce time and labor cost
    - 7.3.1.1.2 NextSeq
      - 7.3.1.1.2.1 Introduction of advanced systems to affect demand for NextSeq
    - 7.3.1.1.3 MiSeq
      - 7.3.1.1.3.1 Small size and rapid operations to drive adoption in clinical labs
    - 7.3.1.1.4 MiniSeq
      - 7.3.1.1.4.1 Cross-application flexibility and small footprint to propel demand
    - 7.3.1.1.5 iSeq 100
      - 7.3.1.1.5.1 High accuracy and lower costs to support market growth
  - 7.3.1.2 Thermo Fisher Scientific
  - 7.3.1.3 PacBio
  - 7.3.1.4 Oxford Nanopore Technologies
  - 7.3.1.5 Other sequencing platforms
- 7.3.2 LIBRARY PREPARATION PLATFORMS
  - 7.3.2.1 Rising demand for sequencing in clinical applications to drive market
7.4 BIOINFORMATICS TOOLS
- 7.4.1 DATA ANALYSIS SOFTWARE & WORKBENCHES
  - 7.4.1.1 Demand for genome analysis in clinical diagnostics to support market growth
- 7.4.2 DATA VISUALIZATION TOOLS
  - 7.4.2.1 Rising demand for sequencing-based research to support market growth
- 7.4.3 OTHER BIOINFORMATICS TOOLS

8 NEXT-GENERATION SEQUENCING PLATFORMS MARKET, BY TECHNOLOGY

8.1 INTRODUCTION
8.2 SEQUENCING BY SYNTHESIS
- 8.2.1 HIGH, RAPID PRODUCTION OF BASE PAIRS TO SUPPORT ADOPTION
8.3 ION SEMICONDUCTOR SEQUENCING
- 8.3.1 SIMPLER WORKFLOW AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH
8.4 SMRT SEQUENCING
- 8.4.1 RAPID RESULTS AND LOWER SEQUENCING COSTS TO DRIVE MARKET
8.5 NANOPORE SEQUENCING
- 8.5.1 DIRECT RNA SEQUENCING CAPABILITIES TO PROPEL DEMAND
8.6 OTHER SEQUENCING TECHNOLOGIES

9 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY WORKFLOW

9.1 INTRODUCTION
9.2 SEQUENCING
- 9.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET
9.3 PRESEQUENCING
- 9.3.1 DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO BOOST MARKET GROWTH
9.4 DATA ANALYSIS
- 9.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE MARKET

10 NEXT-GENERATION SEQUENCING PRODUCTS MARKET, BY END USER

10.1 INTRODUCTION
10.2 ACADEMIC & RESEARCH INSTITUTES
- 10.2.1 RISING RESEARCH INTENSITY FOR GENOME RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH
10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 10.3.1 RISING DEMAND FOR COMPREHENSIVE SEQUENCING DATA IN GENETIC RESEARCH TO DRIVE MARKET
10.4 CLINICAL & DIAGNOSTIC LABORATORIES
- 10.4.1 INCREASED APPLICATIONS IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
10.5 OTHER END USERS

11 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE

11.1 INTRODUCTION
11.2 SEQUENCING SERVICES
- 11.2.1 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS
  - 11.2.1.1 Development of technologically advanced NGS products and services to propel growth
- 11.2.2 RNA SEQUENCING
  - 11.2.2.1 Technological advancements to support market growth
- 11.2.3 DE NOVO SEQUENCING
  - 11.2.3.1 Rising awareness of De Novo sequencing to drive market
- 11.2.4 CHIP SEQUENCING
  - 11.2.4.1 Increased demand for ChIP sequencing to propel growth
- 11.2.5 WHOLE-GENOME SEQUENCING
  - 11.2.5.1 Reduced cost of WGS to support market growth
- 11.2.6 METHYL SEQUENCING
  - 11.2.6.1 Increased demand for methyl sequencing in cancer research to support market growth
- 11.2.7 OTHER SEQUENCING SERVICES
11.3 PRESEQUENCING SERVICES
- 11.3.1 LIBRARY PREPARATION & TARGET ENRICHMENT
  - 11.3.1.1 Development of advanced library preparation solutions to drive market
- 11.3.2 SAMPLE PREPARATION
  - 11.3.2.1 Development of automated sample preparation solutions to boost growth
- 11.3.3 QUALITY CONTROL
  - 11.3.3.1 Importance of quality control in NGS workflow to boost growth
11.4 BIOINFORMATICS & DATA ANALYSIS SERVICES
- 11.4.1 DATA ANALYSIS
  - 11.4.1.1 Increasing demand for genome analysis for clinical diagnosis to drive market
- 11.4.2 DATA VISUALIZATION & INTERPRETATION
  - 11.4.2.1 Rising demand for sequencing-based research to support market growth
- 11.4.3 DATA STORAGE & MANAGEMENT
  - 11.4.3.1 Demand for effective data management to propel market growth
11.5 NGS PLATFORM SERVICES
- 11.5.1 NEED FOR COMPLIANCE AND MINIMIZING PLATFORM DOWNTIME TO DRIVE ADOPTION

12 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY WORKFLOW

12.1 INTRODUCTION
12.2 SEQUENCING
- 12.2.1 RISING DEMAND FOR SEQUENCING SERVICES AND APPLICATIONS IN CLINICAL DIAGNOSTICS TO SUPPORT MARKET GROWTH
12.3 PRESEQUENCING SERVICES
- 12.3.1 CUSTOM DEVELOPMENT OF SAMPLES FOR SEQUENCING TO BOOST MARKET GROWTH
12.4 DATA ANALYSIS SERVICES
- 12.4.1 RISING DEMAND FOR ADVANCED RESEARCH TO DRIVE MARKET

13 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER

13.1 INTRODUCTION
13.2 ACADEMIC & RESEARCH INSTITUTES
- 13.2.1 RISING RESEARCH INTENSITY TO SUPPORT MARKET GROWTH
13.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 13.3.1 RISING DEMAND FOR COMPREHENSIVE GENETIC DATA TO DRIVE GROWTH
13.4 HOSPITALS & CLINICAL LABORATORIES
- 13.4.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT TO DRIVE MARKET GROWTH
13.5 OTHER END USERS

14 NEXT-GENERATION SEQUENCING MARKET, BY APPLICATION

14.1 INTRODUCTION
14.2 DIAGNOSTICS
- 14.2.1 CANCER DIAGNOSTICS
  - 14.2.1.1 Rising demand for targeted therapies to drive market
- 14.2.2 INFECTIOUS DISEASE DIAGNOSTICS
  - 14.2.2.1 Rising demand for comprehensive genomic data in clinical diagnostics to propel adoption
- 14.2.3 REPRODUCTIVE HEALTH DIAGNOSTICS
  - 14.2.3.1 Focus on genetic disease diagnostics to drive growth
- 14.2.4 OTHER DIAGNOSTIC APPLICATIONS
14.3 DRUG DISCOVERY & DEVELOPMENT
- 14.3.1 PHARMACOGENOMICS
  - 14.3.1.1 Rising use of NGS for understanding genomic variants in humans to drive growth
- 14.3.2 OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS
14.4 AGRICULTURE & ANIMAL RESEARCH
- 14.4.1 EMPHASIS ON IMPROVING CROP PRODUCTIVITY TO DRIVE ADOPTION OF NGS
14.5 OTHER APPLICATIONS

15 NEXT-GENERATION SEQUENCING MARKET, BY REGION

15.1 INTRODUCTION
15.2 NORTH AMERICA
- 15.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
- 15.2.2 US
  - 15.2.2.1 US expected to dominate market in North America
- 15.2.3 CANADA
  - 15.2.3.1 Increasing government initiatives in sequencing research to boost market growth
15.3 EUROPE
- 15.3.1 EUROPE: MACROECONOMIC OUTLOOK
- 15.3.2 GERMANY
  - 15.3.2.1 Germany to dominate European NGS market
- 15.3.3 UK
  - 15.3.3.1 Strategic initiatives and funding for genomics research to support market growth
- 15.3.4 FRANCE
  - 15.3.4.1 Increasing government investment in genomics research to drive growth
- 15.3.5 ITALY
  - 15.3.5.1 Favorable funding scenario to drive adoption of advanced sequencing technology
- 15.3.6 SPAIN
  - 15.3.6.1 Growing focus on advancements in personalized medicine to support market growth
- 15.3.7 NETHERLANDS
  - 15.3.7.1 Well-established research infrastructure to sustain demand for NGS
- 15.3.8 REST OF EUROPE
15.4 ASIA PACIFIC
- 15.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
- 15.4.2 CHINA
  - 15.4.2.1 China to dominate Asia Pacific market during forecast period
- 15.4.3 JAPAN
  - 15.4.3.1 Rising number of collaborations in NGS to drive market
- 15.4.4 INDIA
  - 15.4.4.1 Government and private initiatives for genomics projects to propel market
- 15.4.5 AUSTRALIA
  - 15.4.5.1 Increased genetic research in Australia to support market growth
- 15.4.6 SOUTH KOREA
  - 15.4.6.1 Demand for advanced sequencing technologies to support market growth in South Korea
- 15.4.7 REST OF ASIA PACIFIC
15.5 LATIN AMERICA
- 15.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
- 15.5.2 BRAZIL
  - 15.5.2.1 Increased government investments in genomics advancements to drive market
- 15.5.3 MEXICO
  - 15.5.3.1 Rising demand for chronic disease treatment to support market growth in Mexico
- 15.5.4 REST OF LATIN AMERICA
15.6 MIDDLE EAST
- 15.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK
- 15.6.2 GCC COUNTRIES
  - 15.6.2.1 Saudi Arabia
    - 15.6.2.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth
  - 15.6.2.2 UAE
    - 15.6.2.2.1 Collaborations to advance genome sequencing and market growth
  - 15.6.2.3 Rest of GCC Countries
- 15.6.3 REST OF MIDDLE EAST
15.7 AFRICA
- 15.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET
- 15.7.2 AFRICA: MACROECONOMIC OUTLOOK

16 COMPETITIVE LANDSCAPE

16.1 INTRODUCTION
16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 16.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NGS MARKET
16.3 REVENUE ANALYSIS, 2019-2023
16.4 MARKET SHARE ANALYSIS, 2023
16.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 16.5.1 STARS
- 16.5.2 EMERGING LEADERS
- 16.5.3 PERVASIVE PLAYERS
- 16.5.4 PARTICIPANTS
- 16.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 16.5.5.1 Company footprint
  - 16.5.5.2 Region footprint
  - 16.5.5.3 Offering footprint
  - 16.5.5.4 Application footprint
  - 16.5.5.5 Technology footprint
16.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 16.6.1 PROGRESSIVE COMPANIES
- 16.6.2 RESPONSIVE COMPANIES
- 16.6.3 DYNAMIC COMPANIES
- 16.6.4 STARTING BLOCKS
- 16.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 16.6.5.1 Detailed list of key startups/SMEs
  - 16.6.5.2 Competitive benchmarking of startups/SMEs
16.7 VALUATION & FINANCIAL METRICS
- 16.7.1 FINANCIAL METRICS
- 16.7.2 COMPANY VALUATION
16.8 BRAND/PRODUCT COMPARISON
16.9 COMPETITIVE SCENARIO
- 16.9.1 DEALS
- 16.9.2 EXPANSIONS

17 COMPANY PROFILES

17.1 KEY PLAYERS
- 17.1.1 ILLUMINA, INC.
  - 17.1.1.1 Business overview
  - 17.1.1.2 Products/services offered
  - 17.1.1.3 Recent developments
    - 17.1.1.3.1 Product launches
    - 17.1.1.3.2 Deals
    - 17.1.1.3.3 Expansions
  - 17.1.1.4 MnM view
    - 17.1.1.4.1 Key strengths
    - 17.1.1.4.2 Strategic choices
    - 17.1.1.4.3 Weaknesses and competitive threats
- 17.1.2 THERMO FISHER SCIENTIFIC INC.
  - 17.1.2.1 Business overview
  - 17.1.2.2 Products/services offered
  - 17.1.2.3 Recent developments
    - 17.1.2.3.1 Product launches, approvals, and enhancements
    - 17.1.2.3.2 Deals
    - 17.1.2.3.3 Expansions
  - 17.1.2.4 MnM view
    - 17.1.2.4.1 Key strengths
    - 17.1.2.4.2 Strategic choices
    - 17.1.2.4.3 Weaknesses and competitive threats
- 17.1.3 AGILENT TECHNOLOGIES, INC.
  - 17.1.3.1 Business overview
  - 17.1.3.2 Products/services offered
  - 17.1.3.3 Recent developments
    - 17.1.3.3.1 Deals
    - 17.1.3.3.2 Expansions
  - 17.1.3.4 MnM view
    - 17.1.3.4.1 Key strengths
    - 17.1.3.4.2 Strategic choices
    - 17.1.3.4.3 Weaknesses and competitive threats
- 17.1.4 F. HOFFMANN-LA ROCHE LTD.
  - 17.1.4.1 Business overview
  - 17.1.4.2 Products/services offered
  - 17.1.4.3 Recent developments
    - 17.1.4.3.1 Product launches
    - 17.1.4.3.2 Deals
- 17.1.5 DANAHER CORPORATION
  - 17.1.5.1 Business overview
  - 17.1.5.2 Products/services offered
  - 17.1.5.3 Recent developments
    - 17.1.5.3.1 Product launches & approvals
    - 17.1.5.3.2 Deals
    - 17.1.5.3.3 Expansions
- 17.1.6 QIAGEN
  - 17.1.6.1 Business overview
  - 17.1.6.2 Products/services offered
  - 17.1.6.3 Recent developments
    - 17.1.6.3.1 Deals
    - 17.1.6.3.2 Expansions
- 17.1.7 REVVITY
  - 17.1.7.1 Business overview
  - 17.1.7.2 Products/services offered
  - 17.1.7.3 Recent developments
    - 17.1.7.3.1 Product launches
    - 17.1.7.3.2 Deals
    - 17.1.7.3.3 Expansions
- 17.1.8 EUROFINS SCIENTIFIC
  - 17.1.8.1 Business overview
  - 17.1.8.2 Products/services offered
  - 17.1.8.3 Recent developments
    - 17.1.8.3.1 Service launches
    - 17.1.8.3.2 Deals
- 17.1.9 PACBIO
  - 17.1.9.1 Business overview
  - 17.1.9.2 Products/services offered
  - 17.1.9.3 Recent developments
    - 17.1.9.3.1 Product launches
    - 17.1.9.3.2 Deals
    - 17.1.9.3.3 Expansions
    - 17.1.9.3.4 Other developments
- 17.1.10 OXFORD NANOPORE TECHNOLOGIES PLC.
  - 17.1.10.1 Business overview
  - 17.1.10.2 Products/services offered
  - 17.1.10.3 Recent developments
    - 17.1.10.3.1 Product launches
    - 17.1.10.3.2 Deals
- 17.1.11 TAKARA BIO INC.
  - 17.1.11.1 Business overview
  - 17.1.11.2 Products/services offered
  - 17.1.11.3 Recent developments
    - 17.1.11.3.1 Product launches
    - 17.1.11.3.2 Deals
- 17.1.12 BGI GROUP
  - 17.1.12.1 Business overview
  - 17.1.12.2 Products/services offered
  - 17.1.12.3 Recent developments
    - 17.1.12.3.1 Product & service launches and approvals
    - 17.1.12.3.2 Deals
    - 17.1.12.3.3 Other developments
- 17.1.13 BD
  - 17.1.13.1 Business overview
  - 17.1.13.2 Products/services offered
  - 17.1.13.3 Recent developments
    - 17.1.13.3.1 Product & service launches
    - 17.1.13.3.2 Deals
- 17.1.14 10X GENOMICS
  - 17.1.14.1 Business overview
  - 17.1.14.2 Products/services offered
  - 17.1.14.3 Recent developments
    - 17.1.14.3.1 Product launches
- 17.1.15 PROMEGA CORPORATION
  - 17.1.15.1 Business overview
  - 17.1.15.2 Products/services offered
  - 17.1.15.3 Recent developments
    - 17.1.15.3.1 Expansions
- 17.1.16 LGC LIMITED
  - 17.1.16.1 Business overview
  - 17.1.16.2 Products/services offered
    - 17.1.16.2.1 Deals
- 17.1.17 WUXI BIOLOGICS
  - 17.1.17.1 Business overview
  - 17.1.17.2 Products/services offered
- 17.1.18 TECAN TRADING AG
  - 17.1.18.1 Business overview
  - 17.1.18.2 Products/services offered
    - 17.1.18.2.1 Deals
- 17.1.19 TWIST BIOSCIENCES
  - 17.1.19.1 Business overview
  - 17.1.19.2 Products/services offered
  - 17.1.19.3 Recent developments
    - 17.1.19.3.1 Product launches
    - 17.1.19.3.2 Deals
- 17.1.20 AZENTA US, INC.
  - 17.1.20.1 Business overview
  - 17.1.20.2 Products & services offered
  - 17.1.20.3 Recent developments
    - 17.1.20.3.1 Deals
17.2 OTHER PLAYERS
- 17.2.1 MGI TECH CO. LTD.
- 17.2.2 NOVOGENE CO., LTD.
- 17.2.3 NEW ENGLAND BIOLABS
- 17.2.4 GENSCRIPT
- 17.2.5 PSOMAGEN
- 17.2.6 ZYMO RESEARCH CORPORATION
- 17.2.7 HAMILTON COMPANY
- 17.2.8 NEOGENOMICS LABORATORIES
- 17.2.9 FULGENT GENETICS
- 17.2.10 SD BIOSENSOR, INC.

18 APPENDIX

18.1 DISCUSSION GUIDE
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
18.3 CUSTOMIZATION OPTIONS
18.4 RELATED REPORTS
18.5 AUTHOR DETAILS

简介目录图表

List of Tables

TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
TABLE 2 NGS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 9 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022-2024 (USD)
TABLE 10 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022-2024 (USD)
TABLE 11 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD)
TABLE 12 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)
TABLE 13 INNOVATIONS AND PATENT REGISTRATIONS, 2020-2024
TABLE 14 NGS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 15 NGS MARKET: LIST OF KEY CONFERENCES AND EVENTS
TABLE 16 NGS MARKET: IMPACT OF PORTER'S FIVE FORCES
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)
TABLE 18 KEY BUYING CRITERIA, BY END USER
TABLE 19 IMPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 20 IMPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019-2023 (TONS)
TABLE 21 EXPORT DATA FOR HS CODE 3822 (VALUE), BY COUNTRY, 2019-2023 (USD THOUSAND)
TABLE 22 EXPORT DATA FOR HS CODE 3822 (VOLUME), BY COUNTRY, 2019-2023 (TONS)
TABLE 23 NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 24 NGS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 25 NORTH AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 26 EUROPE: NGS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC: NGS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 28 LATIN AMERICA: NGS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 29 MIDDLE EAST: NGS PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 30 GCC COUNTRIES: NGS PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 31 NGS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 32 NORTH AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 33 EUROPE: NGS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC: NGS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 35 LATIN AMERICA: NGS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 36 MIDDLE EAST: NGS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 37 GCC COUNTRIES: NGS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 38 NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 39 NGS CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 40 NORTH AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 41 EUROPE: NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 42 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 43 LATIN AMERICA: NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 44 MIDDLE EAST: NGS CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 45 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 46 NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 47 LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 48 NORTH AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 49 EUROPE: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 50 ASIA PACIFIC: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 51 LATIN AMERICA: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 52 MIDDLE EAST: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 53 GCC COUNTRIES: LIBRARY PREPARATION KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 54 SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 55 NORTH AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 56 EUROPE: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 57 ASIA PACIFIC: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 58 LATIN AMERICA: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 59 MIDDLE EAST: SEQUENCING KITS & REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 60 GCC COUNTRIES: SEQUENCING KITS & REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 61 OTHER NGS CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 62 NORTH AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 63 EUROPE: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 64 ASIA PACIFIC: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 65 LATIN AMERICA: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 66 MIDDLE EAST: OTHER NGS CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 67 GCC COUNTRIES: OTHER NGS CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 68 NGS PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 69 NORTH AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 70 EUROPE: NGS PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 71 ASIA PACIFIC: NGS PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 72 LATIN AMERICA: NGS PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 73 MIDDLE EAST: NGS PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 74 GCC COUNTRIES: NGS PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 75 NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 76 SEQUENCING PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 77 NORTH AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 78 EUROPE: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 79 ASIA PACIFIC: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 80 LATIN AMERICA: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 81 MIDDLE EAST: SEQUENCING PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 82 GCC COUNTRIES: SEQUENCING PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 83 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 84 ILLUMINA SEQUENCING PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 85 ILLUMINA SEQUENCING PLATFORMS MARKET, BY TYPE, 2022-2029 (UNITS)
TABLE 86 NOVASEQ SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 87 NEXTSEQ SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 88 MISEQ SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 89 MINISEQ SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 90 ISEQ SYSTEMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 91 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 92 THERMO FISHER SCIENTIFIC SEQUENCING PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 93 PACBIO SEQUENCING PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 94 OXFORD NANOPORE TECHNOLOGIES SEQUENCING PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 95 LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 96 NORTH AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 97 EUROPE: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 98 ASIA PACIFIC: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 99 LATIN AMERICA: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 100 MIDDLE EAST: LIBRARY PREPARATION PLATFORMS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 101 GCC COUNTRIES: LIBRARY PREPARATION PLATFORMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 102 NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 103 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 104 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 105 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 106 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 107 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 108 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 109 NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 110 DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 111 NORTH AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 112 EUROPE: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 113 ASIA PACIFIC: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 114 LATIN AMERICA: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 115 MIDDLE EAST: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 116 GCC COUNTRIES: DATA ANALYSIS SOFTWARE & WORKBENCHES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 117 DATA VISUALIZATION TOOLS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 118 NORTH AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 119 EUROPE: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 120 ASIA PACIFIC: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 121 LATIN AMERICA: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 122 MIDDLE EAST: DATA VISUALIZATION TOOLS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 123 GCC COUNTRIES: DATA VISUALIZATION TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 124 OTHER BIOINFORMATICS TOOLS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 125 NORTH AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 126 EUROPE: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 127 ASIA PACIFIC: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 128 LATIN AMERICA: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 129 MIDDLE EAST: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 130 GCC COUNTRIES: OTHER BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 131 NGS TECHNOLOGIES, BY COMPANY
TABLE 132 NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 133 NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2022-2029 (USD MILLION)
TABLE 134 NORTH AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 135 EUROPE: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 137 LATIN AMERICA: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 138 MIDDLE EAST: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION, 2022-2029 (USD MILLION)
TABLE 139 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SEQUENCING BY SYNTHESIS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 140 NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 141 NORTH AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 142 EUROPE: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 143 ASIA PACIFIC: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 144 LATIN AMERICA: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 145 MIDDLE EAST: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 146 GCC COUNTRIES: NGS PLATFORMS MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 147 NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 148 NORTH AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 149 EUROPE: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 150 ASIA PACIFIC: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 151 LATIN AMERICA: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 152 MIDDLE EAST: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 153 GCC COUNTRIES: NGS PLATFORMS MARKET FOR SMRT SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 154 NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 155 NORTH AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 156 EUROPE: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 157 ASIA PACIFIC: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 158 LATIN AMERICA: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 159 MIDDLE EAST: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 160 GCC COUNTRIES: NGS PLATFORMS MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 161 NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 162 NORTH AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 163 EUROPE: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 164 ASIA PACIFIC: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 165 LATIN AMERICA: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 166 MIDDLE EAST: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 167 GCC COUNTRIES: NGS PLATFORMS MARKET FOR OTHER SEQUENCING TECHNOLOGIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 168 NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 169 NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 170 NORTH AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 171 EUROPE: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 172 ASIA PACIFIC: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 173 LATIN AMERICA: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 174 MIDDLE EAST: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 175 GCC COUNTRIES: NGS PRODUCTS MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 176 NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 177 NORTH AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 178 EUROPE: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 179 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 180 LATIN AMERICA: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 181 MIDDLE EAST: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 182 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 183 NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 184 NORTH AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 185 EUROPE: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 186 ASIA PACIFIC: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 187 LATIN AMERICA: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 188 MIDDLE EAST: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 189 GCC COUNTRIES: NGS PRODUCTS MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 190 NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 191 NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 192 NORTH AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 193 EUROPE: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 194 ASIA PACIFIC: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 195 LATIN AMERICA: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 196 MIDDLE EAST: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 197 GCC COUNTRIES: NGS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 198 NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 199 NORTH AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 200 EUROPE: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 201 ASIA PACIFIC: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 202 LATIN AMERICA: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 203 MIDDLE EAST: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 204 GCC COUNTRIES: NGS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 205 NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 206 NORTH AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 207 EUROPE: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 208 ASIA PACIFIC: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 209 LATIN AMERICA: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 210 MIDDLE EAST: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 211 GCC COUNTRIES: NGS PRODUCTS MARKET FOR CLINICAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 212 NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 213 NORTH AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 214 EUROPE: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 215 ASIA PACIFIC: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 216 LATIN AMERICA: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 217 MIDDLE EAST: NGS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 218 GCC COUNTRIES: NGS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 219 NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 220 NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 221 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 222 EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 223 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 224 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 225 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 226 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 227 NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 228 EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 229 NORTH AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 230 EUROPE: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 231 ASIA PACIFIC: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 232 LATIN AMERICA: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 233 MIDDLE EAST: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 234 GCC COUNTRIES: EXOME & TARGETED RESEQUENCING AND CUSTOM PANELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 235 RNA SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 236 NORTH AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 237 EUROPE: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 238 ASIA PACIFIC: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 239 LATIN AMERICA: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 240 MIDDLE EAST: RNA SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 241 GCC COUNTRIES: RNA SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 242 DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 243 NORTH AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 244 EUROPE: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 245 ASIA PACIFIC: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 246 LATIN AMERICA: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 247 MIDDLE EAST: DE NOVO SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 248 GCC COUNTRIES: DE NOVO SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 249 CHIP SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 250 NORTH AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 251 EUROPE: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 252 ASIA PACIFIC: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 253 LATIN AMERICA: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 254 MIDDLE EAST: CHIP SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 255 GCC COUNTRIES: CHIP SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 256 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 257 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 258 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 259 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 260 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 261 MIDDLE EAST: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 262 GCC COUNTRIES: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 263 NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 264 NORTH AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 265 EUROPE: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 266 ASIA PACIFIC: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 267 LATIN AMERICA: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 268 MIDDLE EAST: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY REGION, 2022-2029 (USD MILLION)
TABLE 269 GCC COUNTRIES: NEXT-GENERATION SEQUENCING MARKET FOR METHYL SEQUENCING, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 270 OTHER SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 271 NORTH AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 272 EUROPE: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 273 ASIA PACIFIC: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 274 LATIN AMERICA: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 275 MIDDLE EAST: OTHER SEQUENCING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 276 GCC COUNTRIES: OTHER SEQUENCING SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 277 NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 278 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 279 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 280 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 281 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 282 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 283 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 284 NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 285 LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 286 NORTH AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 287 EUROPE: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 288 ASIA PACIFIC: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 289 LATIN AMERICA: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 290 MIDDLE EAST: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 291 GCC COUNTRIES: LIBRARY PREPARATION & TARGET ENRICHMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 292 SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 293 NORTH AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 294 EUROPE: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 295 ASIA PACIFIC: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 296 LATIN AMERICA: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 297 MIDDLE EAST: SAMPLE PREPARATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 298 GCC COUNTRIES: SAMPLE PREPARATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 299 QUALITY CONTROL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 300 NORTH AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 301 EUROPE: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 302 ASIA PACIFIC: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 303 LATIN AMERICA: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 304 MIDDLE EAST: QUALITY CONTROL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 305 GCC COUNTRIES: QUALITY CONTROL SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 306 NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 307 NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 308 EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 309 ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 310 LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 311 MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 312 GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 313 NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 314 DATA ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 315 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 316 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 317 ASIA PACIFIC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 318 LATIN AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 319 MIDDLE EAST: DATA ANALYSIS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 320 GCC COUNTRIES: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 321 DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 322 NORTH AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 323 EUROPE: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 324 ASIA PACIFIC: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 325 LATIN AMERICA: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 326 MIDDLE EAST: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 327 GCC COUNTRIES: DATA VISUALIZATION & INTERPRETATION SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 328 DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 329 NORTH AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 330 EUROPE: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 331 ASIA PACIFIC: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 332 LATIN AMERICA: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 333 MIDDLE EAST: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 334 GCC COUNTRIES: DATA STORAGE & MANAGEMENT SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 335 NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 336 NORTH AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 337 EUROPE: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 338 ASIA PACIFIC: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 339 LATIN AMERICA: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 340 MIDDLE EAST: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY REGION, 2022-2029 (USD MILLION)
TABLE 341 GCC COUNTRIES: NGS SERVICES MARKET FOR NGS PLATFORM SERVICES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 342 NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 343 NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 344 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 345 EUROPE: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 346 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 347 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 348 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 349 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 350 NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 351 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 352 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 353 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 354 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 355 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 356 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 357 NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 358 NORTH AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 359 EUROPE: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 360 ASIA PACIFIC: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 361 LATIN AMERICA: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 362 MIDDLE EAST: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY REGION, 2022-2029 (USD MILLION)
TABLE 363 GCC COUNTRIES: NGS SERVICES MARKET FOR DATA ANALYSIS PHASE, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 364 NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 365 NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 366 NORTH AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 367 EUROPE: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 368 ASIA PACIFIC: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 369 LATIN AMERICA: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 370 MIDDLE EAST: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
TABLE 371 GCC COUNTRIES: NGS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 372 NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 373 NORTH AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 374 EUROPE: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 375 ASIA PACIFIC: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 376 LATIN AMERICA: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 377 MIDDLE EAST: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 378 GCC COUNTRIES: NGS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 379 NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 380 NORTH AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 381 EUROPE: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 382 ASIA PACIFIC: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 383 LATIN AMERICA: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 384 MIDDLE EAST: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
TABLE 385 GCC COUNTRIES: NGS SERVICES MARKET FOR HOSPITALS & CLINICAL LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 386 NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 387 NORTH AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 388 EUROPE: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 389 ASIA PACIFIC: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 390 LATIN AMERICA: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 391 MIDDLE EAST: NGS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
TABLE 392 GCC COUNTRIES: NGS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 393 NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 394 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 395 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 396 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 397 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 398 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 399 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 400 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 401 NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 402 FUNDING AND GRANTS FOR CANCER RESEARCH, BY TYPE (AS OF JANUARY 2023)
TABLE 403 NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 404 NORTH AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 405 EUROPE: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 406 ASIA PACIFIC: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 407 LATIN AMERICA: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 408 MIDDLE EAST: NGS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 409 GCC COUNTRIES: NGS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 410 NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 411 NORTH AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 412 EUROPE: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 413 ASIA PACIFIC: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 414 LATIN AMERICA: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 415 MIDDLE EAST: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 416 GCC COUNTRIES: NGS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 417 NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 418 NORTH AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 419 EUROPE: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 420 ASIA PACIFIC: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 421 LATIN AMERICA: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 422 MIDDLE EAST: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 423 GCC COUNTRIES: NGS MARKET FOR REPRODUCTIVE HEALTH DIAGNOSTICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 424 NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 425 NORTH AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 426 EUROPE: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 427 ASIA PACIFIC: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 428 LATIN AMERICA: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 429 MIDDLE EAST: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 430 GCC COUNTRIES: NGS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 431 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 432 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 433 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 434 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 435 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 436 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 437 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 438 NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 439 NGS MARKET FOR PHARMACOGENOMICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 440 NORTH AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 441 EUROPE: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 442 ASIA PACIFIC: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 443 LATIN AMERICA: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 444 MIDDLE EAST: NGS MARKET FOR PHARMACOGENOMICS, BY REGION, 2022-2029 (USD MILLION)
TABLE 445 GCC COUNTRIES: NGS MARKET FOR PHARMACOGENOMICS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 446 NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 447 NORTH AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 448 EUROPE: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 449 ASIA PACIFIC: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 450 LATIN AMERICA: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 451 MIDDLE EAST: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 452 GCC COUNTRIES: NGS MARKET FOR OTHER DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 453 NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 454 NORTH AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 455 EUROPE: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 456 ASIA PACIFIC: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 457 LATIN AMERICA: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 458 MIDDLE EAST: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2022-2029 (USD MILLION)
TABLE 459 GCC COUNTRIES: NGS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 460 NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 461 NORTH AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 462 EUROPE: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 463 ASIA PACIFIC: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 464 LATIN AMERICA: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 465 MIDDLE EAST: NGS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
TABLE 466 GCC COUNTRIES: NGS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 467 NGS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 468 NORTH AMERICA: KEY MACROINDICATORS
TABLE 469 NORTH AMERICA: NGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 470 NORTH AMERICA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 471 NORTH AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 472 NORTH AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 473 NORTH AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 474 NORTH AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 475 NORTH AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 476 NORTH AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 477 NORTH AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 478 NORTH AMERICA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 479 NORTH AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 480 NORTH AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 481 NORTH AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 482 NORTH AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 483 NORTH AMERICA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 484 NORTH AMERICA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 485 NORTH AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 486 NORTH AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 487 US: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 488 US: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 489 US: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 490 US: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 491 US: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 492 US: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 493 US: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 494 US: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 495 US: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 496 US: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 497 US: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 498 US: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 499 US: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 500 US: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 501 US: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 502 US: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 503 US: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 504 CANADA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 505 CANADA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 506 CANADA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 507 CANADA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 508 CANADA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 509 CANADA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 510 CANADA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 511 CANADA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 512 CANADA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 513 CANADA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 514 CANADA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 515 CANADA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 516 CANADA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 517 CANADA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 518 CANADA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 519 CANADA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 520 CANADA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 521 EUROPE: KEY MACROINDICATORS
TABLE 522 EUROPE: NGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 523 EUROPE: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 524 EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 525 EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 526 EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 527 EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 528 EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 529 EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 530 EUROPE: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 531 EUROPE: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 532 EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 533 EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 534 EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 535 EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 536 EUROPE: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 537 EUROPE: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 538 EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 539 EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 540 GERMANY: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 541 GERMANY: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 542 GERMANY: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 543 GERMANY: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 544 GERMANY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 545 GERMANY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 546 GERMANY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 547 GERMANY: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 548 GERMANY: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 549 GERMANY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 550 GERMANY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 551 GERMANY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 552 GERMANY: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 553 GERMANY: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 554 GERMANY: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 555 GERMANY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 556 GERMANY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 557 UK: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 558 UK: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 559 UK: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 560 UK: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 561 UK: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 562 UK: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 563 UK: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 564 UK: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 565 UK: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 566 UK: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 567 UK: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 568 UK: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 569 UK: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 570 UK: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 571 UK: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 572 UK: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 573 UK: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 574 FRANCE: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 575 FRANCE: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 576 FRANCE: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 577 FRANCE: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 578 FRANCE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 579 FRANCE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 580 FRANCE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 581 FRANCE: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 582 FRANCE: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 583 FRANCE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 584 FRANCE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 585 FRANCE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 586 FRANCE: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 587 FRANCE: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 588 FRANCE: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 589 FRANCE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 590 FRANCE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 591 ITALY: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 592 ITALY: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 593 ITALY: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 594 ITALY: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 595 ITALY: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 596 ITALY: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 597 ITALY: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 598 ITALY: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 599 ITALY: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 600 ITALY: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 601 ITALY: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 602 ITALY: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 603 ITALY: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 604 ITALY: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 605 ITALY: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 606 ITALY: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 607 ITALY: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 608 SPAIN: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 609 SPAIN: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 610 SPAIN: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 611 SPAIN: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 612 SPAIN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 613 SPAIN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 614 SPAIN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 615 SPAIN: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 616 SPAIN: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 617 SPAIN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 618 SPAIN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 619 SPAIN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 620 SPAIN: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 621 SPAIN: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 622 SPAIN: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 623 SPAIN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 624 SPAIN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 625 NETHERLANDS: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 626 NETHERLANDS: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 627 NETHERLANDS: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 628 NETHERLANDS: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 629 NETHERLANDS: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 630 NETHERLANDS: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 631 NETHERLANDS: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 632 NETHERLANDS: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 633 NETHERLANDS: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 634 NETHERLANDS: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 635 NETHERLANDS: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 636 NETHERLANDS: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 637 NETHERLANDS: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 638 NETHERLANDS: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 639 NETHERLANDS: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 640 NETHERLANDS: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 641 NETHERLANDS: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 642 REST OF EUROPE: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 643 REST OF EUROPE: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 644 REST OF EUROPE: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 645 REST OF EUROPE: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 646 REST OF EUROPE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 647 REST OF EUROPE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 648 REST OF EUROPE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 649 REST OF EUROPE: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 650 REST OF EUROPE: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 651 REST OF EUROPE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 652 REST OF EUROPE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 653 REST OF EUROPE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 654 REST OF EUROPE: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 655 REST OF EUROPE: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 656 REST OF EUROPE: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 657 REST OF EUROPE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 658 REST OF EUROPE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 659 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 660 ASIA PACIFIC: NGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 661 ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 662 ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 663 ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 664 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 665 ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 666 ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 667 ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 668 ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 669 ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 670 ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 671 ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 672 ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 673 ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 674 ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 675 ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 676 ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 677 ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 678 CHINA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 679 CHINA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 680 CHINA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 681 CHINA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 682 CHINA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 683 CHINA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 684 CHINA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 685 CHINA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 686 CHINA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 687 CHINA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 688 CHINA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 689 CHINA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 690 CHINA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 691 CHINA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 692 CHINA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 693 CHINA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 694 CHINA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 695 JAPAN: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 696 JAPAN: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 697 JAPAN: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 698 JAPAN: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 699 JAPAN: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 700 JAPAN: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 701 JAPAN: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 702 JAPAN: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 703 JAPAN: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 704 JAPAN: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 705 JAPAN: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 706 JAPAN: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 707 JAPAN: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 708 JAPAN: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 709 JAPAN: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 710 JAPAN: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 711 JAPAN: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 712 INDIA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 713 INDIA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 714 INDIA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 715 INDIA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 716 INDIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 717 INDIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 718 INDIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 719 INDIA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 720 INDIA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 721 INDIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 722 INDIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 723 INDIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 724 INDIA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 725 INDIA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 726 INDIA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 727 INDIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 728 INDIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 729 AUSTRALIA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 730 AUSTRALIA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 731 AUSTRALIA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 732 AUSTRALIA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 733 AUSTRALIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 734 AUSTRALIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 735 AUSTRALIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 736 AUSTRALIA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 737 AUSTRALIA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 738 AUSTRALIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 739 AUSTRALIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 740 AUSTRALIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 741 AUSTRALIA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 742 AUSTRALIA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 743 AUSTRALIA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 744 AUSTRALIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 745 AUSTRALIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 746 SOUTH KOREA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 747 SOUTH KOREA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 748 SOUTH KOREA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 749 SOUTH KOREA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 750 SOUTH KOREA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 751 SOUTH KOREA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 752 SOUTH KOREA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 753 SOUTH KOREA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 754 SOUTH KOREA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 755 SOUTH KOREA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 756 SOUTH KOREA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 757 SOUTH KOREA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 758 SOUTH KOREA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 759 SOUTH KOREA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 760 SOUTH KOREA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 761 SOUTH KOREA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 762 SOUTH KOREA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 763 REST OF ASIA PACIFIC: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 764 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 765 REST OF ASIA PACIFIC: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 766 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 767 REST OF ASIA PACIFIC: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 768 REST OF ASIA PACIFIC: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 769 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 770 REST OF ASIA PACIFIC: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 771 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 772 REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 773 REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 774 REST OF ASIA PACIFIC: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 775 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 776 REST OF ASIA PACIFIC: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 777 REST OF ASIA PACIFIC: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 778 REST OF ASIA PACIFIC: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 779 REST OF ASIA PACIFIC: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 780 LATIN AMERICA: KEY MACROINDICATORS
TABLE 781 LATIN AMERICA: NGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 782 LATIN AMERICA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 783 LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 784 LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 785 LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 786 LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 787 LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 788 LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 789 LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 790 LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 791 LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 792 LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 793 LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 794 LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 795 LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 796 LATIN AMERICA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 797 LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 798 LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 799 BRAZIL: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 800 BRAZIL: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 801 BRAZIL: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 802 BRAZIL: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 803 BRAZIL: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 804 BRAZIL: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 805 BRAZIL: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 806 BRAZIL: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 807 BRAZIL: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 808 BRAZIL: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 809 BRAZIL: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 810 BRAZIL: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 811 BRAZIL: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 812 BRAZIL: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 813 BRAZIL: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 814 BRAZIL: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 815 BRAZIL: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 816 MEXICO: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 817 MEXICO: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 818 MEXICO: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 819 MEXICO: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 820 MEXICO: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 821 MEXICO: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 822 MEXICO: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 823 MEXICO: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 824 MEXICO: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 825 MEXICO: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 826 MEXICO: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 827 MEXICO: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 828 MEXICO: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 829 MEXICO: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 830 MEXICO: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 831 MEXICO: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 832 MEXICO: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 833 REST OF LATIN AMERICA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 834 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 835 REST OF LATIN AMERICA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 836 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 837 REST OF LATIN AMERICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 838 REST OF LATIN AMERICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 839 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 840 REST OF LATIN AMERICA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 841 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 842 REST OF LATIN AMERICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 843 REST OF LATIN AMERICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 844 REST OF LATIN AMERICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 845 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 846 REST OF LATIN AMERICA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 847 REST OF LATIN AMERICA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 848 REST OF LATIN AMERICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 849 REST OF LATIN AMERICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 850 MIDDLE EAST: KEY MACROINDICATORS
TABLE 851 MIDDLE EAST: NGS MARKET, BY REGION, 2022-2029 (USD MILLION)
TABLE 852 MIDDLE EAST: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 853 MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 854 MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 855 MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 856 MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 857 MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 858 MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 859 MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 860 MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 861 MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 862 MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 863 MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 864 MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 865 MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 866 MIDDLE EAST: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 867 MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 868 MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 869 GCC COUNTRIES: NGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
TABLE 870 GCC COUNTRIES: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 871 GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 872 GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 873 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 874 GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 875 GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 876 GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 877 GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 878 GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 879 GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 880 GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 881 GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 882 GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 883 GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 884 GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 885 GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 886 GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 887 SAUDI ARABIA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 888 SAUDI ARABIA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 889 SAUDI ARABIA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 890 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 891 SAUDI ARABIA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 892 SAUDI ARABIA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 893 SAUDI ARABIA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 894 SAUDI ARABIA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 895 SAUDI ARABIA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 896 SAUDI ARABIA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 897 SAUDI ARABIA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 898 SAUDI ARABIA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 899 SAUDI ARABIA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 900 SAUDI ARABIA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 901 SAUDI ARABIA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 902 SAUDI ARABIA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 903 SAUDI ARABIA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 904 UAE: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 905 UAE: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 906 UAE: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 907 UAE: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 908 UAE: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 909 UAE: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 910 UAE: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 911 UAE: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 912 UAE: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 913 UAE: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 914 UAE: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 915 UAE: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 916 UAE: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 917 UAE: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 918 UAE: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 919 UAE: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 920 UAE: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 921 REST OF GCC COUNTRIES: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 922 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 923 REST OF GCC COUNTRIES: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 924 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 925 REST OF GCC COUNTRIES: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 926 REST OF GCC COUNTRIES: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 927 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 928 REST OF GCC COUNTRIES: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 929 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 930 REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 931 REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 932 REST OF GCC COUNTRIES: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 933 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 934 REST OF GCC COUNTRIES: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 935 REST OF GCC COUNTRIES: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 936 REST OF GCC COUNTRIES: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 937 REST OF GCC COUNTRIES: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 938 REST OF MIDDLE EAST: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 939 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 940 REST OF MIDDLE EAST: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 941 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 942 REST OF MIDDLE EAST: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 943 REST OF MIDDLE EAST: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 944 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 945 REST OF MIDDLE EAST: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 946 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 947 REST OF MIDDLE EAST: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 948 REST OF MIDDLE EAST: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 949 REST OF MIDDLE EAST: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 950 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 951 REST OF MIDDLE EAST: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 952 REST OF MIDDLE EAST: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 953 REST OF MIDDLE EAST: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 954 REST OF MIDDLE EAST: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 955 MACROECONOMIC OUTLOOK FOR NGS MARKET IN AFRICA
TABLE 956 AFRICA: NGS MARKET, BY OFFERING, 2022-2029 (USD MILLION)
TABLE 957 AFRICA: NGS PRODUCTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 958 AFRICA: NGS CONSUMABLES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 959 AFRICA: NGS PLATFORMS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 960 AFRICA: NGS BIOINFORMATICS TOOLS MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 961 AFRICA: NGS PLATFORMS MARKET, BY TECHNOLOGY, 2022-2029 (USD MILLION)
TABLE 962 AFRICA: NGS PRODUCTS MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 963 AFRICA: NGS PRODUCTS MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 964 AFRICA: NGS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
TABLE 965 AFRICA: NGS SERVICES MARKET FOR PRESEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 966 AFRICA: NGS SERVICES MARKET FOR SEQUENCING SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 967 AFRICA: NGS SERVICES MARKET FOR BIOINFORMATICS & DATA ANALYSIS SERVICES, BY TYPE, 2022-2029 (USD MILLION)
TABLE 968 AFRICA: NGS SERVICES MARKET, BY WORKFLOW, 2022-2029 (USD MILLION)
TABLE 969 AFRICA: NGS SERVICES MARKET, BY END USER, 2022-2029 (USD MILLION)
TABLE 970 AFRICA: NGS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 971 AFRICA: NGS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 972 AFRICA: NGS MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY TYPE, 2022-2029 (USD MILLION)
TABLE 973 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN NGS MARKET
TABLE 974 NGS MARKET: DEGREE OF COMPETITION
TABLE 975 NGS MARKET: REGION FOOTPRINT
TABLE 976 NGS MARKET: OFFERING FOOTPRINT
TABLE 977 NGS MARKET: APPLICATION FOOTPRINT
TABLE 978 NGS PLATFORMS MARKET: TECHNOLOGY FOOTPRINT
TABLE 979 NGS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 980 NGS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
TABLE 981 NGS MARKET: DEALS, JANUARY 2021- DECEMBER 2024
TABLE 982 NGS MARKET: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 983 ILLUMINA: COMPANY OVERVIEW
TABLE 984 ILLUMINA: PRODUCTS/SERVICES OFFERED
TABLE 985 ILLUMINA: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 986 ILLUMINA: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 987 ILLUMINA: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 988 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
TABLE 989 THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 990 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS, JANUARY 2021-DECEMBER 2024
TABLE 991 THERMO FISHER SCIENTIFIC: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 992 THERMO FISHER SCIENTIFIC: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 993 AGILENT TECHNOLOGIES: COMPANY OVERVIEW
TABLE 994 AGILENT TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
TABLE 995 AGILENT TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 996 AGILENT TECHNOLOGIES: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 997 AGILENT TECHNOLOGIES: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 998 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
TABLE 999 F. HOFFMANN-LA ROCHE: PRODUCTS/SERVICES OFFERED
TABLE 1000 F. HOFFMANN-LA ROCHE: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1001 F. HOFFMANN-LA ROCHE: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1002 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 1003 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 1004 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-DECEMBER 2024
TABLE 1005 DANAHER CORPORATION: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1006 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 1007 QIAGEN: COMPANY OVERVIEW
TABLE 1008 QIAGEN: PRODUCTS/SERVICES OFFERED
TABLE 1009 QIAGEN: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1010 QIAGEN: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1011 QIAGEN: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 1012 REVVITY: COMPANY OVERVIEW
TABLE 1013 REVVITY: PRODUCTS/SERVICES OFFERED
TABLE 1014 REVVITY: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1015 REVVITY: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1016 REVVITY: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 1017 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
TABLE 1018 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 1019 EUROFINS SCIENTIFIC: SERVICE LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1020 EUROFINS SCIENTIFIC: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1021 PACBIO: COMPANY OVERVIEW
TABLE 1022 PACBIO: PRODUCTS/SERVICES OFFERED
TABLE 1023 PACBIO: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1024 PACBIO: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1025 PACBIO: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 1026 PACBIO: OTHER DEVELOPMENTS, JANUARY 2021-DECEMBER 2024
TABLE 1027 OXFORD NANOPORE TECHNOLOGIES: COMPANY OVERVIEW
TABLE 1028 OXFORD NANOPORE TECHNOLOGIES: PRODUCTS/SERVICES OFFERED
TABLE 1029 OXFORD NANOPORE TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1030 OXFORD NANOPORE TECHNOLOGIES: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1031 TAKARA BIO: COMPANY OVERVIEW
TABLE 1032 TAKARA BIO: PRODUCTS/SERVICES OFFERED
TABLE 1033 TAKARA BIO: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1034 TAKARA BIO: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1035 BGI GROUP: COMPANY OVERVIEW
TABLE 1036 BGI GROUP: PRODUCTS/SERVICES OFFERED
TABLE 1037 BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021-DECEMBER 2024
TABLE 1038 BGI GROUP: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1039 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2021-DECEMBER 2024
TABLE 1040 BD: COMPANY OVERVIEW
TABLE 1041 BD: PRODUCTS/SERVICES OFFERED
TABLE 1042 BD: PRODUCT & SERVICE LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1043 BD: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1044 10X GENOMICS: COMPANY OVERVIEW
TABLE 1045 10X GENOMICS: PRODUCTS/SERVICES OFFERED
TABLE 1046 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1047 PROMEGA CORPORATION: COMPANY OVERVIEW
TABLE 1048 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 1049 PROMEGA CORPORATION: EXPANSIONS, JANUARY 2021-DECEMBER 2024
TABLE 1050 LGC LIMITED: COMPANY OVERVIEW
TABLE 1051 LGC LIMITED: PRODUCTS/SERVICES OFFERED
TABLE 1052 LGC LIMITED: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1053 WUXI BIOLOGICS: COMPANY OVERVIEW
TABLE 1054 WUXI BIOLOGICS: PRODUCTS/SERVICES OFFERED
TABLE 1055 TECAN TRADING AG: COMPANY OVERVIEW
TABLE 1056 TECAN TRADING AG: PRODUCTS/SERVICES OFFERED
TABLE 1057 TECAN TRADING AG: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1058 TWIST BIOSCIENCE: COMPANY OVERVIEW
TABLE 1059 TWIST BIOSCIENCE: PRODUCTS/SERVICES OFFERED
TABLE 1060 TWIST BIOSCIENCES: PRODUCT LAUNCHES, JANUARY 2021-DECEMBER 2024
TABLE 1061 TWIST BIOSCIENCE: DEALS, JANUARY 2021-DECEMBER 2024
TABLE 1062 AZENTA US: COMPANY OVERVIEW
TABLE 1063 AZENTA US: PRODUCTS & SERVICES OFFERED
TABLE 1064 AZENTA US: DEALS, JANUARY 2021-DECEMBER 2024

List of Figures

FIGURE 1 RESEARCH DESIGN
FIGURE 2 NGS MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
FIGURE 3 NGS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF ILLUMINA, INC. (2023)
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 8 NGS MARKET: CAGR PROJECTIONS
FIGURE 9 DATA TRIANGULATION METHODOLOGY
FIGURE 10 NGS MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)
FIGURE 11 NGS PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 12 NGS PLATFORMS MARKET, BY TECHNOLOGY 2024 VS. 2029 (USD MILLION)
FIGURE 13 NGS SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 14 NGS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 15 NGS SERVICES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 16 NGS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 17 TECHNOLOGICAL ADVANCEMENTS IN GENOME SEQUENCING TO DRIVE MARKET GROWTH
FIGURE 18 CONSUMABLES ACCOUNTED FOR LARGEST SHARE IN ASIA PACIFIC IN 2023
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 20 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE PRODUCTS MARKET DURING FORECAST PERIOD
FIGURE 21 NGS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS
FIGURE 23 NGS MARKET: VALUE CHAIN ANALYSIS
FIGURE 24 VALUE CHAIN ANALYSIS: SEQUENCING & ANALYSIS ADD MAXIMUM VALUE
FIGURE 25 AVERAGE SELLING PRICE OF INSTRUMENTS, BY KEY PLAYER, 2024 (USD)
FIGURE 26 AVERAGE SELLING PRICE OF CONSUMABLES, BY KEY PLAYER, 2024 (USD)
FIGURE 27 AVERAGE SELLING PRICE OF SERVICES, 2024 (USD)
FIGURE 28 AVERAGE SELLING PRICE OF INSTRUMENTS, BY REGION, 2024 (USD)
FIGURE 29 PATENT ANALYSIS FOR NGS MARKET, 2014-2024
FIGURE 30 NGS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 31 NGS MARKET: ECOSYSTEM ANALYSIS
FIGURE 32 NGS MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FIGURE 34 KEY BUYING CRITERIA, BY END USER
FIGURE 35 RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS, 2020-2024 (USD MILLION)
FIGURE 36 IMPACT OF AI/GEN AI ON NEXT-GENERATION SEQUENCING MARKET
FIGURE 37 NORTH AMERICA: NGS MARKET SNAPSHOT
FIGURE 38 ASIA PACIFIC: NGS MARKET SNAPSHOT
FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN NGS MARKET, 2019-2023 (USD MILLION)
FIGURE 40 NGS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
FIGURE 41 NGS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 42 NGS MARKET: COMPANY FOOTPRINT
FIGURE 43 NGS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 44 EV/EBITDA OF KEY VENDORS
FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 46 NGS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 47 ILLUMINA: COMPANY SNAPSHOT (2023)
FIGURE 48 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2023)
FIGURE 49 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2023)
FIGURE 50 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2023)
FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2023)
FIGURE 53 REVVITY: COMPANY SNAPSHOT (2023)
FIGURE 54 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
FIGURE 55 PACBIO: COMPANY SNAPSHOT (2023)
FIGURE 56 OXFORD NANOPORE TECHNOLOGIES: COMPANY SNAPSHOT (2023)
FIGURE 57 TAKARA BIO: COMPANY SNAPSHOT (2023)
FIGURE 58 BD: COMPANY SNAPSHOT (2023)
FIGURE 59 10X GENOMICS: COMPANY SNAPSHOT (2023)
FIGURE 60 LGC LIMITED: COMPANY SNAPSHOT (2023)
FIGURE 61 WUXI BIOLOGICS: COMPANY SNAPSHOT (2023)
FIGURE 62 TECAN TRADING AG: COMPANY SNAPSHOT (2023)
FIGURE 63 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2023)
FIGURE 64 AZENTA US: COMPANY SNAPSHOT (2023)